Skip to main content
Signal8

GARNIER JEAN PIERRE

SEC insider (Form 3/4/5 filer). CIK 0001184175. Director at BioAge Labs, Inc. (BIOA) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in EMERYVILLE, CA.

Companies GARNIER JEAN PIERRE has filed insider reports for

  • BioAge Labs, Inc. (BIOA): Director
  • CARRIER GLOBAL Corp (CARR): Director
GARNIER JEAN PIERRE profile photo

GARNIER JEAN PIERRE

CIK: 0001184175

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BioAge Labs, Inc. logo
BIOA

BioAge Labs, Inc.

Director
CARRIER GLOBAL Corp logo
CARR

CARRIER GLOBAL Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • BioAge Labs, Inc. logo
    BIOA

    BioAge Labs, Inc.

    Jun 10, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    22K shares-
  • CARRIER GLOBAL Corp logo
    CARR

    CARRIER GLOBAL Corp

    Apr 15, 2026
    Award

    Director DSU

    Direct
    3.3K shares at avg. $58.55-
  • BioAge Labs, Inc. logo
    BIOA

    BioAge Labs, Inc.

    Jun 5, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    22K shares-
  • CARRIER GLOBAL Corp logo
    CARR

    CARRIER GLOBAL Corp

    Apr 9, 2025
    Award

    Director DSU

    Direct
    3.2K shares at avg. $60.77-
  • BioAge Labs, Inc. logo
    BIOA

    BioAge Labs, Inc.

    Sep 25, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    15K shares-
  • BioAge Labs, Inc. logo
    BIOA

    BioAge Labs, Inc.

    Aug 19, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    141.6K shares-

1-6 of 6